Journals / Maltepe Tıp Dergisi / 2012 / Cilt: 4 - Sayı: 1

Aging Theories and Treatment Approaches

Yaşlanma Teorileri ve Tedavi Yaklaşımları

Pages
56–61
Publication Date
2012-04-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

İn this review, theories explaining the mechanisms of aging and potential therapeutic approaches are discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aging is an inevitable process that have chronological, psychological, social and biological aspects.
📊
Key Findings & Data:The progressive decrease in physiological capacity and the reduced ability to respond to environmental stresses lead to increased susceptibility and vulnerability to diseases.
💡
Conclusion & Impact:İn this review, theories explaining the mechanisms of aging and potential therapeutic approaches are discussed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Yaşlanma · anti-yaşlanma · mortalite

Abstract

Aging is an inevitable process that have chronological, psychological, social and biological aspects. The progressive decrease in physiological capacity and the reduced ability to respond to environmental stresses lead to increased susceptibility and vulnerability to diseases. Consequently, mortality due to all these causes increases with aging. While many people died at young ages in the past, after the developments in 20th century, people have developed the idea of living longer, 'antiaging' has become a subject of interest and various studies have been done to reveal the causes of aging, to treat aging or to reduce the symptoms of aging. İn this review, theories explaining the mechanisms of aging and potential therapeutic approaches are discussed.

Özet

Yaşlanma kronolojik, psikolojik, toplumsal ve biyolojik yönleri olan kaçınılmaz bir süreçtir. Fizyolojik kapasitedeki ilerleyici azalma ve çevresel streslere cevap verme yeteneğinde azalma, hastalıklara karşı artmış duyarlılık ve hassasiyete yol açmaktadır. Sonuçta, tüm bu nedenlere bağlı olarak yaşlanmayla birlikte mortalite artmaktadır. Geçmişte birçok insan genç yaşta ölürken, 20. yüzyıldaki gelişmeler sonrasında insanlarda daha uzun yaşama fikri oluşmuş, ‘anti-yaşlanma' daha ilgi çeken bir konu haline gelmiş ve yaşlanmanın nedenleri ortaya koymak, yaşlanmayı tedavi etmek ya da belirtilerini azaltmak için çeşitli çalışmalar yapılmıştır. Bu derlemede, yaşlanmanın mekanizmalarını açıklayan teoriler ve muhtemel tedavi yaklaşımları tartışılmaktadır.

🔖

Cite This Article

SAĞLAM, E., ÖZDAMAR, E. N. (2012). Aging Theories and Treatment Approaches. Maltepe Tıp Dergisi, Cilt: 4 - Sayı: 1, 56–61. https://ajindex.com/articles/231100

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Atlı K, Bozcuk AN.: Telomer ve Hücresel Yaşlanma. Turkish Journal of Geriatrics 2002;5(3):111-114. Blasco MA.: Telomere length, stem cells anda aging. Nature Chemical Biology 2007;3(10):640-649. Blagosklonny MV.: An anti- aging drug today: from senescence- promoting genes to anti-aging pill. Drug Discovery Today 2007;12(5/6):218-224. Blagosklonny MV.: Revisiting the antagonistic pleiot- rophy theory of aging TOR-driven program and qua- si-program. Cell Cycle 2010; 9(16):3151-3156.
  2. Gül S, Çetin M, Evrenkaya R, Danacı M, Küçükardalı Y.: Yaşlılık, Yaşlanmanın Biyolojisi ve Psikolojisi. T Klin Tıp Bilimleri 1993;13:238-248. Zengin G,Başak T.: Deri Yaşlanması. T Klin Tıp Bilimle- ri 1991;11:506-510.
  3. Dönderici L, Taşpınar A.: Deri Yaşlanması. Turk J Der- matol 1994;4: 56-61. Blagosklonny MV.: Validation of anti-aging drugs by treating age-related diseases. Aging 2009;1(3): 281- 288. Heilbronn LK, Ravussin E.: Calorie restriction and aging: review of the literature and implications for studies in humans. Am J Clin Nutr 2003;78:361-369.
  4. Holloszy JO, Fontana L.: Caloric restriction in humans. Exp Gerontol 2007; 42(8):709-712.
  5. Kennedy BK, Steffen KK, Kaeberlein M.: Ruminations on dietary restriction and aging. Cell Mol. Life Sci. 2007;64:1323-1328. Anisimov VN. Metformin for aging and cancer pre- vention. Aging 2010; 2(11):760-774.
  6. Anisimov VN, Berstein LM, Egormin PA, Piskunova TS, Popovich IG, Zabezhinski MA et al.: Effect of metfor- min on life span and on the development of sponta- neous mammary tumors in HER-2/neu transgenic mi- ce. Exp. Gerontol 2005;40:685-693.
  7. Anisimov VN, Berstein LM, Egormin PA, Piskunova TS, Popovich IG, Zabezhinski MA et al.: Metformin slows down aging and extends life span of female SHR mi- ce. Cell Cycle 2008; 7(17):2769-2773.
  8. Buzzai M, Jones RG, Amaravadi RK, Lum JJ, DeBerar- dinis RJ, Zhao F et al.: Systemic treatment with the an- tidiabetic drug metformin selectively impairs p53-de- ficient tumor cell growth. Cancer Res 2007;67(14): 6745-6752.
  9. Evans JMM, Donnely LA, Emslie-Smith AM, Alessi DR, Morris AD.: Metformin and reduced risk of cancer in diabetic patients. BMJ 2005;330:1304-1305.
  10. Libby G, Donnely LA, Donan PT, Alessi DR, Morris AD, Evans JMM.: New users of metformin are at low risk of incident cancer. Diabetes Care 2009; 32(9):1620- 1625. Sahra IB, Marchand-Brustel YLM, Tanti JF, Bost F.: Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther 2010; 9(5):1092-1099.
  11. Sirtori CR, Catapano A,